Showing results (1041-1050 of 4,424) with videos related to
Sort By:
Pageof 443
Cancer Cell International|August 7, 2026
NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor modelsMykola Lyndin, Michel Janicot, Justus Müller, et al.Cancer Cell International|December 8, 2022
Landmarks in pancreatic cancer studiesFan Xu, Min Huang, Yun Bai, et al.Cancer Cell International|December 9, 2022
BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional cultureHilda Samimi, Rezvan Tavakoli, Parviz Fallah, et al.Cancer Cell International|December 12, 2022
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cellsDanilo Swann Matassa, Daniela Criscuolo, Rosario Avolio, et al.Cancer Cell International|December 13, 2022
Natural essential oils as a new therapeutic tool in colorectal cancerStefania Garzoli, Pedro Alarcón-Zapata, Gulnaz Seitimova, et al.Cancer Cell International|May 6, 2022
TNFRSF13B is a potential contributor to prostate cancerChia-Yang Li, Shu-Pin Huang, Yei-Tsung Chen, et al.Cancer Cell International|November 24, 2022
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progressionMichelle Junyi He, Wenjun Pu, Xi Wang, et al.Cancer Cell International|July 5, 2022
A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progressionSoudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.Cancer Cell International|July 5, 2022
Lipid metabolism in tumor microenvironment: novel therapeutic targetsXingkai Liu, Ping Zhang, Jing Xu, et al.Cancer Cell International|December 9, 2022
Potential of Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, as a hot tumor inducerTakayuki Horii, Yuki Orikawa, Yuta Ohira, et al.Pageof 443